Inflammatory Bowel Diseases 1990
Editat de D. Rachmilewitz, George O Zimmermanen Limba Engleză Hardback – 28 feb 1990
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1345.51 lei 6-8 săpt. | |
| Springer – 21 apr 2014 | 1345.51 lei 6-8 săpt. | |
| Hardback (1) | 1359.13 lei 6-8 săpt. | |
| Springer – 28 feb 1990 | 1359.13 lei 6-8 săpt. |
Preț: 1359.13 lei
Preț vechi: 1430.66 lei
-5%
Puncte Express: 2039
Preț estimativ în valută:
240.36€ • 278.40$ • 208.72£
240.36€ • 278.40$ • 208.72£
Carte tipărită la comandă
Livrare economică 20 aprilie-04 mai
Specificații
ISBN-13: 9780792306573
ISBN-10: 0792306570
Pagini: 280
Ilustrații: XII, 280 p.
Dimensiuni: 160 x 241 x 21 mm
Greutate: 0.61 kg
Ediția:1990 edition
Editura: Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0792306570
Pagini: 280
Ilustrații: XII, 280 p.
Dimensiuni: 160 x 241 x 21 mm
Greutate: 0.61 kg
Ediția:1990 edition
Editura: Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
IBD: the present situation and a glimpse of the promised land.- IBD: the present situation and a glimpse of the promised land.- I: Etiology.- Is IBD a genetic disease?.- Glycoprotein structure and ulcerative colitis.- Barrier function of intestinal epithelial tight junctions (TJ).- Are mycobacteria the cause of Crohn’s disease?.- Smoking and inflammatory bowel disease.- II: Pathogenesis and experimental models.- Role of platelet activating factor and interleukin I in the pathogenesis of inflammatory bowel disease.- Is there a primary defect in the host defense mechanism in IBD?.- Evidence against a defect in immune host defenses as a primary process in IBD.- Animal models of inflammatory bowel disease.- III: Clinical assessment.- Why the variation in colitic cancer rates from different centres.- Is there any benefit from cancer surveillance in ulcerative colitis?.- Endoscopy in IBD — what has it accomplished?.- The problem of postoperative recurrence of Crohn’s disease.- Endoscopic examination of the small bowel in idiopathic inflammatory bowel diseases.- IV: Nutrition and metabolic implications.- Crohn’s disease in children and adolescents: diminished growth velocity.- Skeletal complications of inflammatory bowel disease.- Enteral nutrition in inflammatory bowel disease.- Total parenteral nutrition in the management of inflammatory bowel disease: an update.- V: Medical management.- 5-ASA in ulcerative colitis.- 5-ASA preparations in the treatment of inflammatory bowel disease.- 4-amino salicylic acid in the treatment of ulcerative colitis: preliminary report of a randomized double-blind placebo controlled trial of oral 4-ASA.- Olsalazine (Dipentum®): the first choice in the treatment of ulcerative colitis.- Immunosuppressive drugs: do they have any role in thetreatment of IBD? (A).- Immunosuppressive drugs: do they have any role in the treatment of IBD? (B).- Cyclosporin in inflammatory bowel disease.- Use of methotrexate for refractory inflammatory bowel disease.- Therapeutic strategies in IBD: Case discussion with computer-aided audience participation.- Index of subjects.